Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a catheter, cable, balloon, and generator and has received FDA approval in the United States. Information collected in this study will be analyzed to better understand the long-term safety and effectiveness of treatment with the Paradise System for patients with high blood pressure.
Location: SIMR (Sacramento/Valley Area)
Please contact: SIMR@sutterhealth.org about Recor US GPS
Principal Investigator
Co-Investigator(s)
Syed Latif, MD, David K. Roberts, III, M.D., FACC, Pei-Hsiu Huang, M.D.
Related Studies
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD
Prevalence, Treatment and Outcomes of Asian Subgroups with Coronary Artery Disease in the U.S.
Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator
Cardiovascular Disease Among Asians and Pacific Islanders (CASPER)
Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator
Research Aimed at Improving Both Mood and Weight (RAINBOW)
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
Investigator: Bob S. Hu, M.D.
Integrated Examination of Myocardial Ischemia with Magnetic Resonance
Investigator: Bob S. Hu, M.D.
Comprehensive Assessment of Valvular Function with MRI
Investigator: Bob S. Hu, M.D.
Clinical MRI of Peripheral Arterial Disease
Investigator: Bob S. Hu, M.D.